Your session is about to expire
← Back to Search
Device
TearCare for Meibomian Gland Dysfunction (OLYMPIA Trial)
N/A
Recruiting
Research Sponsored by Sight Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
OLYMPIA Trial Summary
TearCare System to Treat Dry Eye Disease
Eligible Conditions
- Meibomian Gland Dysfunction
- Dry Eye Syndrome
OLYMPIA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Meibomian Gland Secretion Score
Tear Break-Up Time
Secondary outcome measures
Conjunctival staining score
Corneal staining score
Eye Dryness Score
+4 moreOLYMPIA Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TearCareExperimental Treatment1 Intervention
Subjects will have heat applied to the eyelids for 15 minutes followed by manual expression of the meibomian glands.
Group II: LipiFlowActive Control1 Intervention
Subjects will have heat and pressure applied to the eyelids for 12 minutes.
Find a Location
Who is running the clinical trial?
Sight Sciences, Inc.Lead Sponsor
12 Previous Clinical Trials
877 Total Patients Enrolled
1 Trials studying Meibomian Gland Dysfunction
350 Patients Enrolled for Meibomian Gland Dysfunction
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger